Hide Board Information

Show Board Information

Morris Business Development Company MBDE

Board Mod: Digimaster

Asst Mods: Riggler

Last Post: 07/15/2014 6:19:02 AM

Board Marks: 1

Posts Today: 0

Board Views Today: 4

Morris Business Development Company (OTCMRKTS: MBDE) Stock Message Board

1. MBDE Company Profile

    

2. MBDE Time & Sales

    

3. MBDE Recent News

    

4. MBDE Filings

    

5. MBDE Financials

    

6. MBDE Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	MBDE Financials Tuesday, July 15, 2014 06:19:00	Emylers	07/15/2014 6:19:02 AM
5	Latest Morris Business Devl (MBDE) Headlines	Stock_Tracker	03/10/2014 12:34:03 PM
4	MBDE 0.025 Stock Charts $MBDE 1 Month Chart	chartguy89	03/08/2014 9:21:33 AM
3	MBDE Stock Charts Last: -0.005 Thursday, February	chartguy89	02/27/2014 5:44:08 PM
2	Maybe ;/	th3xf4ctor	06/04/2013 3:23:11 PM
1	WHY WHAT DO WE HAVE HERE A BDC	WARMBUFFETT	06/01/2013 2:16:36 PM

Recent Articles

• October Sees Singapore's Core Inflation Drop to 2.1%
• UniCredit's Ambitious $10.57 Billion Acquisition Offer Explained
• Markets React to U.S. Treasury Secretary Choice and Impacts
• Australian Stocks Surge Higher: S&P/ASX 200 Climbs to Record
• COP29 Outcomes Reveal Strains in Global Climate Agreements
• TTA and O-RAN Alliance Unite to Enhance Open RAN Standards
• UPL Partners with CH4 Global to Revolutionize Livestock Feed
• Marc Randolph's Perspective on Wealth and Meaningful Living
• BR Companies Plans New Luxury High-rise to Revitalize Downtown
• COP29 Climate Negotiations Yield Uncertain Business Prospects
• Gold Prices Dip as Tensions Ease Between Conflict Factions
• Dogecoin Eyes $1 as Bitcoin Struggles with Key Resistance
• Marc Benioff Envisions the Future of AI Beyond Chatbots
• Adani Group Share Recovery Amid Recent Legal Challenges
• Asian Market Rally: Cyclical Stocks Lead Gains Amid Optimism
• Australia's New Social Media Rules for Under-16s Explained
• Apple CEO's Beijing Visit Boosts Supplier Stocks Significantly
• Examining the Overvaluation of MicroStrategy Stock Today
• Light & Wonder, Inc.: Legal Scrutiny and Stockholder Insights
• Australia's Bold Move to Safeguard Children's Privacy Online
• Pathway to Growth: Palantir's Ambitious AI Future and Price Target
• Challenges Faced by Chinese Startups Amidst Investment Landscape
• Explore the Growth of Bluesky Amid Social Media Changes
• Elon Musk Amused by Bitcoin's Dip After Analyst's Praise
• Mynaric AG Faces Class Action Lawsuit: What Investors Should Know
• Iris Energy Investors Urged to Join Class Action Lawsuit
• Terran Orbital Faces Class Action Lawsuit: What Investors Should Know
• Franklin Resources Faces Investigation: What Investors Should Know
• Class Action Lawsuit Filed Against Xiao-I Corporation: Key Insights
• Quanterix Under Investigation for Financial Mismanagement Concerns
• Evolv Technologies Faces Class Action Lawsuit Amid Financial Concerns
• Marqeta Faces Legal Scrutiny Amid Revenue Forecast Cuts
• Investigation into The Estée Lauder Companies, Inc. Begins
• Class Action Lawsuit Impacting iLearningEngines Investors
• Flux Power's Legal Challenges: What Investors Should Know
• Class Action Lawsuit Filed Against Acadia Healthcare: Key Insights
• Explore Apple’s Exciting Black Friday Gift Card Promotions
• ONEOK Expands Reach with $4.3 Billion EnLink Acquisition
• Investors on Alert: Class Action Lawsuit Filed Against WM Technology
• Adani Group Faces Bond Market Turmoil Amid Fraud Claims
• Impact of New Tax Policies on British Business Investment Trends
• Strong Demand for Electric Vehicles Anticipated Until 2024
• Bitcoin's Resilience Amid Market Fluctuations This Thanksgiving
• SG Fleet Group Surges Amid $785 Million Buyout Talks
• Intel Adjusts to Reduced CHIPS Act Funding Amid Challenges
• U.S. Government Adjusts Intel's Chips Grant to Below $8 Billion
• Oil Prices Stabilize: Middle East Tensions and Ceasefire Talks
• Geopolitical Tensions Propel Oil Prices: A Two-Week Overview
• Cassava Sciences Announces Important Corporate Conference Call
• Confidence Boost in BioPharma: Impact of Makary's Nomination